Infertility treatments and risk of breast benign diseases: a case‒control study
- PMID: 39482608
- PMCID: PMC11528984
- DOI: 10.1186/s12905-024-03429-w
Infertility treatments and risk of breast benign diseases: a case‒control study
Abstract
Background: Theoretically, endocrine fluctuations occurring during infertility treatments, including ovulation induction (OI) and assisted reproductive techniques (ART), could be associated with an increased risk of benign breast diseases (BBDs). To date, no studies have been conducted on this association. Therefore, the present study investigated the association between different types of infertility treatments and BBDs.
Methods: This case‒control study was conducted in Arash Women's Hospital, Tehran, Iran. The case group included infertile women diagnosed with BBDs without atypia, and the control group included infertile women without breast disease. Breast imaging studies (mammography/ultrasound) were performed for BBD screening, and the diagnosis was confirmed by histopathological examination. Study variables were collected retrospectively from medical records, hospital databases, and questionnaires.
Results: Finally, 154 infertile women, including 50 cases (BBDs) and 104 controls (no BBDs), were compared. Our data showed that 66% of cases and 61.4% of controls had undergone at least one course of infertility treatment. There was no association between BBD risk and previous infertility treatments (OR = 1.21; 95% CI = 0.59-2.46), ART (OR = 1.14; 95% CI = 0.90-1.44), or OI cycles (OR = 1.13; 95% CI = 0.98-1.32). Stratification by confounding variables did not change these results.
Conclusions: It seems that there is no association between BBDs in infertile women and the type, duration, or number of prior infertility treatments; however, considering the small sample size of the study, the clinical significance of this finding should not be neglected. Therefore, we consider it essential to carry out more extensive, detailed, and prospective studies to distinguish the association of BBDs with different infertility treatments and medications.
Keywords: Assisted reproductive techniques; Breast benign diseases; Infertility treatment; Ovarian-stimulating hormones; Ovulation induction.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden.JAMA Netw Open. 2021 Jun 1;4(6):e2114716. doi: 10.1001/jamanetworkopen.2021.14716. JAMA Netw Open. 2021. PMID: 34170304 Free PMC article.
-
Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study.Eur J Epidemiol. 2019 Nov;34(11):1093-1101. doi: 10.1007/s10654-019-00540-3. Epub 2019 Aug 3. Eur J Epidemiol. 2019. PMID: 31377935 Free PMC article.
-
[Reproductive variables and risk of benign breast diseases. A case-control study].Rev Saude Publica. 1990 Oct;24(5):387-93. doi: 10.1590/s0034-89101990000500006. Rev Saude Publica. 1990. PMID: 2101530 Portuguese.
-
Association between ovarian tumors and exposure to assisted reproductive technologies and ovarian stimulation: a systematic review and meta-analysis.Arch Gynecol Obstet. 2024 Dec;310(6):2753-2765. doi: 10.1007/s00404-024-07763-0. Epub 2024 Oct 16. Arch Gynecol Obstet. 2024. PMID: 39412534
-
Review of available infertility treatments.Drugs Today (Barc). 2009 Apr;45(4):275-91. doi: 10.1358/dot.2009.45.4.1360985. Drugs Today (Barc). 2009. PMID: 19499093 Review.
References
-
- El-Wakeel H, Umpleby HC. Systematic review of fibroadenoma as a risk factor for breast cancer. Breast. 2003;12. - PubMed
-
- DL WDD. P. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 312:146–51. - PubMed
-
- Kuang K, Wilson SR. A Meta-Analysis of Uncertainty and Information Management in Illness Contexts. J Communication. 2017;67.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical